Pharmacy

The number of patients who need costly specialty drugs is sharply increasing, according to a recent study by Prime Therapeutics.

Gilead Sciences named Genentech executive Merdad Parsey, MD, PhD, its new CMO, effective Nov. 1.

Pharmaceutical companies in the U.S. are encouraging Mexicans to travel across the border on temporary visas to donate blood plasma in exchange for money, according to ProPublica.

The FDA's approval of the second-ever HIV prevention drug Oct. 3 explicitly excluded women, which some activists and scientists argue sets a dangerous precedent, according to The New York Times.

GlobalData's Pharmaceutical Intelligence Center released a list predicting what the best-selling drugs will be in 2025, according to EndPoints News.

Prescription drug costs will soon rise by as much as 42 percent for military health insurance users, according to Military.com.

Roanoke, Va.-based Carilion Clinic recently purchased two robots to improve drug compounding in its pharmacies, according to local news station WDBJ7.

AstraZeneca's biologic asthma drug Fasenra can now be self-administered by patients after the FDA approved the method of administration in a new prefilled autoinjector.

New Haven, Conn.-based Yale School of Medicine is hiring a postdoctoral fellow to help analyze the public health implications of medical project regulation, clinical trial design and drug-pricing plans.

A former technology executive from Bayer, Jim Swanson, is Johnson & Johnson's new CIO, according to The Wall Street Journal.